简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2026-04-23 11:40 Galderma Shareholders Approve All Annual General Meeting Proposals
2026-04-22 15:30 Agenus Names BAP Pharma as Exclusive Global Partner for BOT+BAL Access Programs
2026-04-22 15:18 Crown Bioscience and Turbine Partner to Connect AI-Driven Prediction with Organoid Validation in Translational Oncology
2026-04-22 14:05 Advised by MAS Capital, Suntec Medical Plans for a US$100M Nasdaq IPO in 2027
2026-04-21 11:00 Cleaner by Design: SaniSure Introduces PETG PharmaTainer™ Ultra-Clean Bottles & Carboys
2026-04-20 17:15 SBC Medical Announces Pricing of Secondary Public Offering of 3.1 Million Shares of Common Stock
2026-04-20 12:03 Byondis to Present Data from its Novel ADC Technology Platforms at the American Society for Cancer Research Meeting 2026
2026-04-20 11:50 Orthogon Therapeutics Raises an Additional $11M Financing for Its BK Virus Antiviral Drug Program
2026-04-17 10:17 Seoul's Myeongdong Now Has a Clinic Where Tourists Get K-Beauty Treatments Between Shopping
2026-04-16 17:47 Got a Layover in Korea? This Clinic Near Incheon Airport Offers Aesthetic Treatments in Under 4 Hours
2026-04-16 17:38 Why Tens of Thousands of Foreign Patients Are Choosing This Gangnam Clinic
2026-04-16 15:31 Ferring Pharmaceuticals and Gallup Announce Landmark Global Public Attitudes Study on Fertility and Family-Building
2026-04-16 15:27 Galderma Launches New Alastin Regenerating Skin Nectar with TriHex+™, Powered by Its Next-Generation TriHex Technology® Regenerative Platform
2026-04-15 10:09 Samsung Bioepis Initiates Phase 1 Clinical Trial for SBE303, Nectin-4 Targeting Antibody-Drug Conjugate (ADC) Candidate
2026-04-10 14:29 ADDING MULTIMEDIA Byondis Appoints Christoph Korpus, PhD, MBA as Chief Executive Officer
2026-04-09 16:04 Americhem Announces Expansion of Global Healthcare Footprint with New China Investment at Chinaplas 2026
2026-04-09 13:35 Interim Data From Two Ongoing Investigator-initiated Trials Highlight the Role of Sculptra® and Restylane® in Addressing Aesthetic Changes Associated With Weight Loss Medications and Menopause
2026-04-08 10:12 Fortitude Biomedicines Announces Lead Program Targeting Disease-Driven T-cell Signaling Pathways for the Treatment of Axial Spondyloarthritis
2026-04-03 14:17 IFF Launches PureStrong™, a Probiotic Made Specifically for Dogs
2026-04-02 13:44 Agenus Announces First Patient Enrolled in Global Phase 3 BATTMAN Trial of BOT+BAL Immunotherapy Combination in MSS or pMMR Metastatic Colorectal Cancer

Business Wire Weibo

Press Releases

Latest Releases